Stock Events

Stock Events

Monopar Therapeutics (MNPR) Q2 2025 Earnings

13MayConfirmed

Q2 2024

Q3 2024

Q4 2024

Q2 2025

-1

-0.7

-0.4

-0.1

Details

Expected EPS

-0.52

Actual EPS

-0.38

Surprise EPS

0.14

Surprise Percent

+26.92%

Description

Monopar Therapeutics (MNPR) has reported earnings of -0.38 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.